ELMD Electromed Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: ELMD

Price (delayed)

$28.1

Market cap

$235.09M

P/E Ratio

20.51

Dividend/share

N/A

EPS

$1.37

Enterprise value

$214.64M

?
Relative Growth: Rel. Growth: 98
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 68
Relative Profitability: Rel. Profitability: 95

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, ...

Highlights
Electromed's EPS has soared by 54% YoY and by 12% from the previous quarter
The net income has grown by 50% year-on-year and by 12% since the previous quarter
The company's quick ratio rose by 8% YoY but it fell by 7% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.smartvest.com
Peers: RMD INGN MMSI

Key stats

What are the main financial stats of ELMD

ELMD stock price

How has the Electromed stock price performed over time
Intraday
-1.4%
1 week
0.79%
1 month
-0.5%
1 year
13.67%
YTD
-3.5%
QTD
-0.46%

Financial performance

How have Electromed's revenue and profit performed over time
Revenue
$73.78M
Gross profit
$57.94M
Operating income
$13.88M
Net income
$11.3M
Gross margin
78.5%
Net margin
15.3%
The net income has grown by 50% year-on-year and by 12% since the previous quarter
ELMD's operating income is up by 44% year-on-year and by 6% since the previous quarter
Electromed's net margin has increased by 30% YoY and by 9% from the previous quarter
Electromed's operating margin has increased by 25% YoY and by 2.7% QoQ

Price vs fundamentals

How does ELMD's price correlate with its fundamentals

Growth

What is Electromed's growth rate over time

Valuation

What is Electromed stock price valuation
ELMD P/E details
P/E
20.51
P/B
4.31
P/S
3.15
EV/EBIT
14.95
EV/EBITDA
13.91
EV/Sales
2.91
Electromed's EPS has soared by 54% YoY and by 12% from the previous quarter
ELMD's P/E is 37% below its 5-year quarterly average of 32.4 and 20% below its last 4 quarters average of 25.6
The equity rose by 25% year-on-year and by 10% since the previous quarter
The price to book (P/B) is 20% higher than the 5-year quarterly average of 3.6 but 15% lower than the last 4 quarters average of 5.1
The stock's price to sales (P/S) is 17% more than its 5-year quarterly average of 2.7 but 10% less than its last 4 quarters average of 3.5
ELMD's revenue is up by 15% year-on-year and by 2.8% since the previous quarter

Efficiency

How efficient is Electromed business performance
The ROE has grown by 34% YoY and by 6% from the previous quarter
The company's return on assets rose by 33% YoY and by 6% QoQ
Electromed's ROS has increased by 21% YoY and by 3.2% from the previous quarter
The ROIC has grown by 20% YoY

Dividends

What is ELMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELMD.

Financial health

How did Electromed financials performed over time
ELMD's total assets is up by 23% YoY and by 11% QoQ
Electromed's total liabilities has increased by 19% QoQ and by 16% YoY
Electromed's debt is 100% less than its equity
The equity rose by 25% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.